हलो इंडिया!

Efferon is now available in India through our partner Helmier and registered as a medical device for use across the country.

With a population of more than 1.4 billion people, India is one of the world’s largest healthcare markets and an important new step for Efferon. The country has a large and growing critical care community, where hashtag#sepsis and severe systemic inflammation remain major challenges.

We look forward to working with Helmier to bring Efferon technology to hospitals and intensive care teams across India.

Welcome to the Efferon community, Helmier!